BioSpace News Archive

Canopy, the Intelligent Care Platform for oncology, announced it has raised $13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins, and Chris Mansi.

Gelesis, the maker of Plenity® for weight management, announced that the Company will report financial results for fiscal year 2021 on March 24, 2022, following the market close.

Evelo Biosciences, Inc. (Nasdaq:EVLO), today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 24, 2022 to report its fourth quarter and full year 2021 financial results and discuss business highlights.

MediWound Ltd., a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, announced financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, today announced the first patient has been dosed in Encore, the Company’s open-label extension (OLE) study for food allergy patients who completed participation in Harmony, its Phase 1/2 study of ADP101.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today provided a corporate update and announced its financial results for the fourth quarter and full year ended December 31, 2021.

Kane Biotech Inc., a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its fourth quarter and full year 2021 financial results after market close on Thursday, March 24, 2022.

Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for cancer patients, will provide a regulatory update on CLN-081 during a webinar being held Monday, March 28, 2022, at 4:30 p.m. ET.

Aadi Bioscience, Inc., a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update.

via NewMediaWire – Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, announced that Todos Medical President CEO Gerald Commissiong will present at the Proactive One2One Virtual Forum on March 17, 2022 at 2:00 PM ET.